SCHEMBL931863

SCHEMBL931863

CSC1=NC(Cc2ccccc2)(c2cccc(Br)c2)N=C1N

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 3/20 0.46
NPSR1 Q6W5P4 1/20 0.38
IDO1 P14902 2/20 0.34
AGXT P21549 2/20 0.34
MEN1 O00255 1/20 0.33
LMNA P02545 1/20 0.33
MAPT P10636 1/20 0.33
HTT P42858 1/20 0.33
KMT2A Q03164 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
APP P05067 2/20 0.33
CTSD P07339 1/20 0.33
HSP90AA1 P07900 1/20 0.32
MAOB P27338 1/20 0.32
TAAR1 Q96RJ0 1/20 0.32
KIF11 P52732 1/20 0.32
KDM1A O60341 1/20 0.31
RCOR1 Q9UKL0 1/20 0.31
THRB P10828 1/20 0.31
RXFP1 Q9HBX9 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL932777 0.83 BACE1 (0.65) BACE1NPSR1IDO1AGXTMEN1
SCHEMBL946696 0.81 BACE1 (0.46) BACE1NPSR1IDO1AGXTMEN1
SCHEMBL6894146 0.71 BACE1 (0.56) BACE1NPSR1MEN1KMT2AAPP
SCHEMBL932646 0.70 BACE1 (0.46) BACE1MEN1KMT2ACTSDMAOB
SCHEMBL6892288 0.69 BACE1 (0.67) BACE1IDO1MEN1KMT2AAPP
SCHEMBL932184 0.68 BACE1 (0.48) BACE1CTSDRXFP1
SCHEMBL945501 0.68 BACE1 (0.47) BACE1MEN1KMT2AAPPCTSD
SCHEMBL931802 0.68 BACE1 (0.38) BACE1CTSD
SCHEMBL932202 0.68 BACE1 (0.34) BACE1MAPTCTSD
SCHEMBL946218 0.67 BACE1 (0.49) BACE1APPCTSD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011002408-A1 NOVEL COMPOUNDS FOR TREATMENT OF NEURODEGENERATION ASSOCIATED WITH DISEASES, SUCH AS ALZHEIMER'S DISEASE OR DEMENTIA ASTRAZENECA AB (SE) 2011-01-06 WO disclosed
WO-2011002408-A1 NOVEL COMPOUNDS FOR TREATMENT OF NEURODEGENERATION ASSOCIATED WITH DISEASES, SUCH AS ALZHEIMER'S DISEASE OR DEMENTIA ASTRAZENECA AB (SE) 2011-01-06 WO disclosed